Antiviral prophylaxis for CMV, HSV/VZV and HBV in allogeneic hematopoietic cell transplantation in adult patients: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
Loading...
Files
Date
Journal Title
Journal ISSN
Volume Title
Publisher
John Libbey Eurotext
Abstract
The Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) organizes annual workshops in the attempt to harmonize clinical practices among different francophone transplantation centers. Here, we report our recommendations regarding the prophylaxis of cytomegalovirus (CMV), herpes simplex virus (HSV), varicella zoster virus (VZV) and hepatitis B virus infection after allogeneic hematopoietic cell transplantation in adult patients. © 2019 Société Française du Cancer
Description
Keywords
Allogeneic stem cell transplantation, Cmv, Hbv, Hsv, Prophylaxis, Vzv, Acetates, Adult, Allografts, Antiviral agents, Cytomegalovirus infections, Hematopoietic stem cell transplantation, Hepatitis b, Herpes simplex, Herpes zoster, Humans, Quinazolines, Transplantation conditioning, Antivirus agent, Acetic acid, Letermovir, Quinazoline derivative, Allogeneic hematopoietic stem cell transplantation, Antiviral therapy, Cytomegalovirus, Cytomegalovirus infection, Hepatitis b virus, Herpes simplex virus, Human, Medical society, Nonhuman, Practice guideline, Review, Varicella zoster virus, Adverse event, Allograft, Consensus development